Below is info on Medarex.
I can not recall them as holder of IDMI stock either. Here is aquestion I have for the board. I remember right after IDM got European approval, the only ana;yst covering the stock (the one that has $1.6 target), spoke on the news and name a company that he saw as a potential partner. I have to admit, I have never heard of that company, and I can not recover this piece from yahoo news to see if the comapny he brought up was in fact Medarex.. Anybody remembers/have thoughts? Thanks.
Medarex is a biopharmaceutical company focused on the discovery, development, and potential commercialization of fully human antibody-based therapeutics to treat life- threatening and debilitating diseases, including cancer, inflammation, autoimmune and infectious diseases. Medarex applies its UltiMAb® technology and product development and clinical manufacturing experience to generate, support and potentially commercialize a broad range of fully human antibody products for itself and its partners. Medarex is committed to building value by developing a diverse pipeline of antibody products to address the world's unmet healthcare needs.
Market Data 
Markets 
AI
